| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/24/2007 | WO2007057756A2 Isocystene derivatives for the treatment of pain |
| 05/24/2007 | WO2007057755A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium |
| 05/24/2007 | WO2007057742A2 Novel piperazinone derivatives |
| 05/24/2007 | WO2007057705A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr) |
| 05/24/2007 | WO2007057691A2 Therapeutic uses of steroidal compounds |
| 05/24/2007 | WO2007057229A1 4-oxadiazolyl-piperidine compounds and use thereof |
| 05/24/2007 | WO2007057212A1 High activity growth factor mutants |
| 05/24/2007 | WO2007057128A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 05/24/2007 | WO2007041035A3 Oral composition and method for stress reduction associated with smoking cessation |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2007037133A9 Method for evaluation of compound capable of acting on plk3 |
| 05/24/2007 | WO2007018738A8 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 05/24/2007 | WO2007017914A3 Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
| 05/24/2007 | WO2007006566A8 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 05/24/2007 | WO2006119758B1 Dihydroxyphenylalanine derivatives |
| 05/24/2007 | WO2006119353A3 Dopamine receptor agonists in the treatment and prevention of hiv-induced dementia |
| 05/24/2007 | WO2006116302A3 High-potency botulinum toxin formulations |
| 05/24/2007 | WO2006091522A3 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 05/24/2007 | WO2006087550A3 Amyloid-binding peptides, analogues and uses thereof |
| 05/24/2007 | WO2004060266A3 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 05/24/2007 | US20070117992 Crystalline citalopram diol intermediate alkali |
| 05/24/2007 | US20070117853 (+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)propoxy)-5-methoxyphenyl]benzothiazoline; kappa -opioid receptor agonist |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117757 Polypeptide copolymer for use in treatment of multiple sclerosis; glatiramer acetate; copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons; chromatographic separation; cleaving by acid hydrolysis or enzymetic hydrolysis; isolation by dialysis or ultrafiltration, |
| 05/24/2007 | US20070117742 producing a fraction enriched in a proteinaceous molecule having N-linked glycans comprising sialyl-Lewis X, Lewis X or LacdiNac structures; cerebral ischemia or myocardial infarction; composition comprising erythropoietin molecules |
| 05/24/2007 | US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 05/24/2007 | US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070117154 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |
| 05/24/2007 | US20070117142 Regulation of novel human asparagine-hydroxylases |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116692 Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116684 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116683 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116682 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070113727 Wireless microphone communication system |
| 05/24/2007 | CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia. |
| 05/24/2007 | CA2630441A1 Therapeutic uses of steroidal compounds |
| 05/24/2007 | CA2629896A1 Isocystene derivatives for the treatment of pain |
| 05/24/2007 | CA2629831A1 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 05/24/2007 | CA2629514A1 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 05/24/2007 | CA2629312A1 Compositions and methods for treating cns disorders |
| 05/24/2007 | CA2629294A1 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin |
| 05/24/2007 | CA2628750A1 4-oxadiazolyl-piperidine compounds and use thereof |
| 05/24/2007 | CA2628179A1 Azaindazoles useful as inhibitors of kinases |
| 05/24/2007 | CA2628145A1 Novel dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other disorders |
| 05/24/2007 | CA2628047A1 Process for production of cinnamide derivative |
| 05/24/2007 | CA2627370A1 High activity growth factor mutants |
| 05/23/2007 | EP1788092A1 Method of inhibiting postischemic reperfusion-induced cell death and cell death inhibitor |
| 05/23/2007 | EP1788086A1 Death Domain Containing Receptor 5 |
| 05/23/2007 | EP1788000A1 Agent for preventing and ameliorating obesity |
| 05/23/2007 | EP1787999A1 Anti-VEGF antibodies |
| 05/23/2007 | EP1787998A1 Antibody and utilization of the same |
| 05/23/2007 | EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 05/23/2007 | EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 05/23/2007 | EP1787679A1 Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain |
| 05/23/2007 | EP1787657A1 Therapeutic agent for psychoneurotic disease |
| 05/23/2007 | EP1787648A1 Medicinal composition for percutaneous perospirone administration |
| 05/23/2007 | EP1786822A1 Fused tricyclic derivatives for the treatment of psychotic disorders |
| 05/23/2007 | EP1786790A1 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 05/23/2007 | EP1786788A1 Substituted triazines as prion protein ligands and their use to detect or remove prions |
| 05/23/2007 | EP1786778A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/23/2007 | EP1786775A1 Dimeric piperidine derivates |
| 05/23/2007 | EP1786769A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 05/23/2007 | EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 05/23/2007 | EP1786766A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 05/23/2007 | EP1786759A1 Novel derivatives of 3,5-seco-4-norcholestane and use thereof |
| 05/23/2007 | EP1786457A1 Use of il-6 in vascular complications |
| 05/23/2007 | EP1786452A1 Use of dm43 and its fragments as matrix metalloproteinases inhibitor |
| 05/23/2007 | EP1786437A2 Improved ghb compositions |
| 05/23/2007 | EP1786423A1 A pharmaceutical composition for treating ataxia, multiple system atrophy or balance disorders |
| 05/23/2007 | EP1786422A2 Aryl urea derivatives for treating obesity |
| 05/23/2007 | EP1786420A1 Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of central neuropathic pain |
| 05/23/2007 | EP1786419A1 Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction |
| 05/23/2007 | EP1786410A2 The treatment of inflammatory disorders and pain |
| 05/23/2007 | EP1786405A2 Compounds and methods for controlling alcohol intake |
| 05/23/2007 | EP1562923B1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/23/2007 | EP1554936B1 Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 05/23/2007 | EP1423384B1 Pyridine derivatives as raf kinase inhibitors |
| 05/23/2007 | EP1363885B1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 05/23/2007 | EP1353910B1 Lactam compound |
| 05/23/2007 | EP1259282A4 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
| 05/23/2007 | EP1257535B1 Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 05/23/2007 | EP1175221B1 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 05/23/2007 | EP0970203B1 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease in humans |
| 05/23/2007 | EP0859777B1 8-azabicyclo(3.2.1)oct-2-ene derivatives, their preparation and use |
| 05/23/2007 | EP0858328B1 Stable compositions containing n-propargyl-1-aminoindan |
| 05/23/2007 | CN1968951A Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-l-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor |
| 05/23/2007 | CN1968945A Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 05/23/2007 | CN1968942A 新颖的四环四氢呋喃衍生物 Novel tetracyclic tetrahydrofuran derivatives |
| 05/23/2007 | CN1968697A Neuroprotective properties of dextrorotatory morphinans |
| 05/23/2007 | CN1968693A Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivative |
| 05/23/2007 | CN1968691A Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 05/23/2007 | CN1966519A Hydrated perindopril salt, preparation method thereof and composition containing the same |
| 05/23/2007 | CN1966500A Quinoxaline derivative, preparation method and uses |
| 05/23/2007 | CN1966080A Neural stem cell injection for treating senile dementia and Parkinson's disease |
| 05/23/2007 | CN1966064A Ointment for removing dampness and relieving pain and preparation method thereof |